Kelly Walworth, PA
Medical · Oklahoma City, OKNPI 1376526756
Payments from drug & device makers
Across 722 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$1K
- Novartis$1K
- Pfizer$1K
- Johnson & Johnson$1K
- Sanofi$1K
- plus $7K from 23 others
What the payments were for
- Consulting fees$8005%
- Food & beverage$13,85291%
- Education$6054%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $2,157 |
| Lilly USA, LLC | 71 | $1,440 |
| Novartis | 85 | $1,421 |
| Pfizer | 63 | $1,339 |
| Johnson & Johnson(2 entities) | 52 | $1,290 |
| Sanofi | 42 | $1,048 |
| Regeneron Healthcare Solutions, Inc. | 41 | $996 |
| UCB, Inc. | 43 | $801 |
| LEO Pharma Inc. | 46 | $784 |
| Sun Pharmaceutical Industries Inc. | 35 | $756 |
| E.r. Squibb & Sons, L.L.C. | 30 | $753 |
| Amgen | 29 | $536 |
| Galderma Laboratories, L.p. | 28 | $421 |
| Arcutis Biotherapeutics, Inc. | 16 | $334 |
| Incyte Corporation | 15 | $291 |
| Genentech USA, Inc. | 11 | $214 |
| Boehringer Ingelheim | 2 | $94 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Mayne Pharma Commercial LLC | 9 | $79 |
| Verrica Pharmaceuticals Inc. | 3 | $72 |
| Biofrontera Inc. | 3 | $62 |
| Nabriva Therapeutics, PLC | 3 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $53 |
| Journey Medical Corporation | 3 | $46 |
| Krystal Biotech Inc | 2 | $33 |
| Dermira, Inc. | 2 | $30 |
| Organon | 2 | $28 |
| Kyowa Kirin, Inc. | 2 | $26 |
| Mylan Institutional Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,257 in reported general payments places this provider in the 95th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $54,125 |
| Clobetasol Propionate | 48 | $4,303 |
| Fluorouracil | 28 | $1,955 |
| Doxycycline Hyclate | 90 | $1,715 |
| ValacyclovirValacyclovir Hcl | 22 | $1,125 |
| Doxycycline Monohydrate | 28 | $1,073 |
| Imiquimod | 16 | $703 |
| CiclopiroxCiclopirox Olamine | 12 | $468 |
| Ciclopirox | 11 | $457 |
| Mupirocin | 67 | $450 |
| Triamcinolone Acetonide | 44 | $417 |
| Ketoconazole | 11 | $288 |
| Hydroxychloroquine Sulfate | 16 | $278 |
Paid to pharmacies, not to this prescriber.
Other medical in Oklahoma City
- Mebin ThomasOklahoma City$323K
- Kristine MurrowOklahoma City$81K
- Katelyn PuryearOklahoma City$22K
- Jere ClaunchOklahoma City$15K
- Vy TranOklahoma City$15K
- Jennifer MinshallOklahoma City$11K
- Lindee LedbetterOklahoma City$10K
- Christina HelmsOklahoma City$7K
- John ParmeleeOklahoma City$6K
- Holly MaxOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.